Vascular Biogenics Ltd. (VBLT) Q4 2019 Results Earnings Conference Call March 19, 2020 8:30 AM ET
Company Participants
Michael Wood - IR, LifeSci Advisors
Dror Harats - CEO
Amos Ron - CFO
Conference Call Participants
Kevin DeGeeter - Oppenheimer
Sam Slutsky - LifSci Capital
Ram Swayampakula - H.C. Wainwright
Soumit Roy - Jones Trading
Jonathan Kreizman - Valore Research
Operator
Greetings and welcome to the VBL Therapeutics Fourth Quarter and Full Year 2019 Earnings Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator instructions]. As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Mr. Michael Wood of LifeSci Advisors. Thank you. You may now begin.
Michael Wood
Thank you, operator. Good morning and thank you all for participating in today’s year-end 2019 results and corporate update call for VBL Therapeutics. Leading the call this morning will be Professor Dror Harats, CEO of the company; and Amos Ron, the company’s CFO. A press release with the financial results became available at 10:00 O’clock Eastern Time today and can be found on Investors page of the company’s website.
Before we begin, I’d like to remind everyone that various remarks about future expectations, plans, prospects, constitute forward-looking statements for the purposes of the Safe Harbor provisions under the Private Securities Litigation Reform Act of 1995. VBL cautions that these forward-looking statements are the subject of risks and uncertainties that could cause actual results to differ materially from those indicated. Any forward-looking statements made on today’s conference call speaks as only of today’s date, Thursday March 19, 2020, and the company does not intend to update any of these forward-looking statements to reflect events or circumstances that occur after today’s date.
As a reminder, the
- Read more current VBLT analysis and news
- View all earnings call transcripts